EUCTR2005-005122-31-DEActive, not recruitingNot Applicable
Evaluation versus placebo of the effects on heart rate, haemodynamic parameters, safety and tolerability of 5 mg bolus of ivabradine followed by 8-hour infusion at the dose of 5 mg of ivabradine given to patients undergoing a percutaneous coronary intervention following a myocardial infarction with ST segment elevation - VIVIFY
Institut de Recherches Internationales0 sites75 target enrollmentStarted: November 29, 2006Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 75
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •- Male or female patients,
- •- aged between 40 and 80 years (inclusive),
- •- HR > 80 bpm in sinus rythm,
- •- patients who are undergoing a Percutaneous Coronary Intervention following an acute myocardial infarction with ST segment elevation.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •- Sick sinus syndrome;
- •- second-degree or third-degree AV block;
- •- trifascicular block and PR > 240 ms;
- •- hypertrophic cardiomyopathy, severe valvular disease, or severe congenital heart disease;
- •- suspected aortic dissection;
- •- known relevant electrolyte disorders.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Evaluation versus placebo of the effects on heart rate, haemodynamic parameters, safety and tolerability of 5 mg bolus of ivabradine followed by 8-hour infusion of 5 mg of ivabradine, given to patients undergoing a percutaneous coronary intervention following a myocardial infarction with ST segment elevation (STEMI)A pilot, blind, randomised, placebo-controlled, international, multi-centre study.Including the ancillary sub-study to the clinical study protocol - VIVIFYAcute Myocardial InfarctionMedDRA version: 3.3Level: PTClassification code 10028596EUCTR2005-005122-31-BEInstitut de Recherches Internationales75
Recruiting
Phase 2
Comparison of cardiovascular effects of ropevacaine and lidocaine with epinephrine in implant surgeryHemodynamic effects.IRCT20211127053190N1Shahid Beheshti University of Medical Sciences18
Active, not recruiting
Not Applicable
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 18.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849EUCTR2012-002742-20-PTInstitut de Recherches Internationales Servier400
Active, not recruiting
Phase 1
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 18.1Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849EUCTR2012-002742-20-DEInstitut de Recherches Internationales Servier400
Active, not recruiting
Phase 1
Effect of ivabradine versus placebo on cardiac function and on capacity to perform exercise in patients suffering from diastolic heart failure.Heart failure with preserved left ventricular ejection fractionMedDRA version: 17.0Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849EUCTR2012-002742-20-ATInstitut de Recherches Internationales Servier400